The increasing prevalence of Coxsackievirus A6 (CVA6) as a major causative agent for Hand, Foot, and Mouth Disease (HFMD) worldwide necessitates the development of an effective vaccine, especially since there is currently no vaccine available against CVA6 infections. CVA6 infections pose a
January 28, 2025A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco
January 16, 2025For more than a century, researchers have relied on two-dimensional (2D) methods to culture plant and animal cells in laboratories, confining cell growth to flat surfaces like tiny petri dishes. However, such methods impose significant limits on how cells grow and interact, often producing less
December 31, 2024A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that coul
December 19, 2024MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
December 18, 2024In the ever-evolving field of biotechnology, cell and gene therapy offer unprecedented potential to treat diseases once considered untreatable. However, recent evidence suggests that the conventional methods of culturing cells might be hindering progress. Researchers are now reconsidering the
December 16, 2024